Advertisement

Topics

Latest "AtEase" News Stories

19:06 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "AtEase" found in our extensive news archives from over 250 global news sources.

More Information about AtEase on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about AtEase for you to read. Along with our medical data and news we also list AtEase Clinical Trials, which are updated daily. BioPortfolio also has a large database of AtEase Companies for you to search.

Showing "AtEase" News Articles, all 5

Relevant

AtEase Donates to Flags for Fort Snelling in Support of Veterans

AtEase, a manufacturer of specialty therapeutic glasses, announced that it will be donating a portion of all sales through May 15, 2018, to Flags for Fort Snelling as part of their ongoing support of military veterans. Flags for Fort Snelling is a non-profit organization working toward honoring every hero laid to rest at Fort Snelling National Cem...


$TNXP will Present Phase 3 HONOR and Phase 2 AtEase Study Results in Poster Presentations at CNS Summit November 2-3 https://globenewswire.com/news-release/2018/10/29/1638134/0/en/Tonix-Pharmaceuticals-will-Present-Phase-3-HONOR-and-Phase-2-AtEase-Study-R

$TNXP will Present Phase 3 HONOR and Phase 2 AtEase Study Results in Poster Presentations at CNS Summit November 2-3 https://globenewswire.com/news-release/2018/10/29/1638134/0/en/Tonix-Pharmaceuticals-will-Present-Phase-3-HONOR-and-Phase-2-AtEase-Study-Results-in-Poster-Presentations-at-CNS-Summit-2018.html …

Tonix Pharmaceuticals will Present Phase 3 HONOR and Phase 2 AtEase Study Results in Poster Presentations at CNS Summit 2018

NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that it will be presenting findings and retrospective analyses from the Phase 3 HONOR study and Phase 2 AtEase Study in two posters at CNS Summit 2018 being held November 1-4, 2018, in Boca Raton, Fla. Details of Poster Presentation #1   


Tonix Pharmaceuticals will Present Phase 3 HONOR and Phase 2 AtEase Study Results in a Poster Presentation at the 2018 Military Health System Research Symposium

NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that it will be presenting findings and retrospective analyses from the Phase 3 HONOR study and Phase 2 AtEase Study in a poster, at the 2018 Military Health System Research Symposium (MHSRS) being held August 20 – 23, 2018, in Kissimmee, Fla.   Details of poster presenta...

Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from the Phase 2 AtEase Study at the American Society of Clinical Psychopharmacology

NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), presented data from the Phase 2 AtEase study of Tonmya®* (cyclobenzaprine HCl sublingual tablets) for the treatment posttraumatic stress disorder (PTSD). The presentation focused on the rationale for including suicidal individuals in the clinical trial of a treatment for PTSD.  “There are...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks